si

Making Education [electronic resource] : Material School Design and Educational Governance




si

The future of work in the Asia Pacific and beyond [electronic resource] : a technological revolution or evolution? / edited by Alan R. Nankervis, Julia Connell and John Burgess

















si

JAMA Cardiology : Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

Interview with Andreas M. Zeiher, MD, author of Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure, and Peter Libby, MD, author of CHIPping Away at the Pathogenesis of Heart Failure





si

JAMA Internal Medicine : Analysis of Proposed Medicare Reforms on Prescription Drug Total Spending and Patient Cost-Sharing

Interview with Aaron Kesselheim, author of Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs, and Francis J. Crosson, M.D., author of Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries











si

JAMA Internal Medicine : Allocation of Inpatient Time Among First-Year Internal Medicine Residents

Interview with Krisda Hirschman Chaiyachati, MD, MPH, MSHP, author of Assessment of Inpatient Time Allocation Among First-Year Internal Medicine Residents Using Time-Motion Observations, and Christopher Moriates, MD, author of A Modern Snapshot of the Daily Work of Medical Interns—The Burden of Indirect Patient Care






si

JAMA Cardiology : Rivaroxaban and Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

Interview with Barry H. Greenberg, author of Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial, and Marvin A. Konstam, MD, author of Antithrombotic Therapy in Heart Failure—The Clot Thickens








si

JAMA Cardiology : Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older

Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients














si

JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide